Design and Evaluation of a Potential Non-Invasive Neurostimulation Strategy for Treating Persistent Anosmia in Post-COVID-19 Patients
A new pandemic was declared at the end of 2019 because of coronavirus disease 2019 (COVID-19). One of the effects of COVID-19 infection is anosmia (i.e., a loss of smell). Unfortunately, this olfactory dysfunction is persistent in around 5% of the world’s population, and there is not an effective tr...
Main Authors: | Desirée I. Gracia, Mario Ortiz, Tatiana Candela, Eduardo Iáñez, Rosa M. Sánchez, Carmina Díaz, José M. Azorín |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Sensors |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8220/23/13/5880 |
Similar Items
-
Ontological Anosmia
by: Andreas Philippopoulos-Mihalopoulos
Published: (2021-12-01) -
Current understanding of neurostimulation for Parkinson's disease
by: Ekaterina V. Bril, et al.
Published: (2022-06-01) -
SUDDEN ANOSMIA - HIDDEN INTIMATION OF NOVEL CORONAVIRUS
by: Sana Abbas, et al.
Published: (2020-09-01) -
Radio-laboratory findings in COVID-19 anosmia patients: a single-center experience
by: Tareq Muhammad Algarf, et al.
Published: (2021-07-01) -
Bilateral olfactory aplasia: Uncommon cause of congenital anosmia
by: Ashraf Nabeel Mahmood, et al.
Published: (2019-07-01)